The expression of hepatic PPARγ was significantly up-regulated in HFD mice and further elevated by 39.3% in HFRD mice (Fig. 4D), suggesting that PPARγ may contribute to the development of NAFLD. The gene discussed is PPARG; the disease is metabolic dysfunction-associated steatotic liver disease.